Early Detection of Secondary Bladder Urothelial Carcinoma and Disseminated Bone Metastases with Normal Prostate-Specific Antigen Level after Pelvic Salvage Radiotherapy in Prostate Cancer.
Teak Jun ShinMisun ChoeByung Hoon KimSang Jun ByunPublished in: Life (Basel, Switzerland) (2023)
This report describes the case of a 65-year-old man who presented with gross hematuria and a history of pelvic salvage radiotherapy for prostate cancer. Cystoscopy and transurethral resection of the bladder revealed urothelial carcinoma. Subsequently, disseminated bone metastases were detected with normal prostate-specific antigen (PSA) levels, and palliative radiotherapy and systemic chemotherapy were administered. Because gross hematuria can appear in both acute/chronic cystitis and bladder cancer in patients who have undergone pelvic radiotherapy for prostate cancer, close follow-up along with a detailed evaluation is needed. In addition, because prostate cancer disease progression with normal PSA levels may be associated with specific pathological findings, a detailed evaluation of symptoms and a careful review of pathologic reports are important.
Keyphrases
- prostate cancer
- locally advanced
- rectal cancer
- radical prostatectomy
- early stage
- neoadjuvant chemotherapy
- radiation therapy
- radiation induced
- end stage renal disease
- spinal cord injury
- ejection fraction
- newly diagnosed
- chronic kidney disease
- palliative care
- liver failure
- drug induced
- peritoneal dialysis
- prognostic factors
- intensive care unit
- physical activity
- muscle invasive bladder cancer
- benign prostatic hyperplasia